Literature DB >> 33280711

2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (Feno) in asthma management.

Brian Lipworth1, Chris RuiWen Kuo2, Rory Chan2.   

Abstract

Entities:  

Keywords:  Asthma; IL-13; fractional exhaled nitric oxide; inhaled corticosteroid; type 2 inflammation

Year:  2020        PMID: 33280711     DOI: 10.1016/j.jaci.2020.03.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  2 in total

1.  2020: The year in review.

Authors:  Zuhair K Ballas
Journal:  J Allergy Clin Immunol       Date:  2020-12-25       Impact factor: 10.793

Review 2.  Understanding the Cellular Sources of the Fractional Exhaled Nitric Oxide (FeNO) and Its Role as a Biomarker of Type 2 Inflammation in Asthma.

Authors:  Jose M Escamilla-Gil; Mar Fernandez-Nieto; Nathalie Acevedo
Journal:  Biomed Res Int       Date:  2022-05-02       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.